From: Comparisons of the survival time of patients with ovarian cancer adopting post-operative chemotherapy by use of paclitaxel combined with carboplatin or nedaplatin
CBP (n = 48)
NDP (n = 46)
Statistics
P value
Age
50.75 ± 8.566
51.87 ± 9.854
t = 0.589
0.558
Pathological type
\( \chi \) 2 = 0.091
0.763
Poorly differentiated adenocarcinoma (30)
16
14
Papillary serous adenocarcinoma (64)
32